| Typicality: | 0.399 |
| Saliency: | 0.223 |
| as part of the approval package | 2 | manner |
| trial → be submitted to → the fda | 9 |
| trial → be reviewed by → the fda | 3 |
| negative | neutral | positive |
| 0.119 | 0.750 | 0.132 |
| Raw frequency | 12 |
| Normalized frequency | 0.223 |
| Modifier score | 0.667 |
| Perplexity | 64.524 |